Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1-Reference-Cited by-同舟云学术

Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1

Published:2014-11-26 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Rudd Meghan L,Mohamed Hassan,Price Jessica C,O’Hara Andrea J,Le Gallo Matthieu,Urick Mary Ellen,Cruz Pedro,Zhang Suiyuan,Hansen Nancy F,Godwin Andrew K,Sgroi Dennis C,Wolfsberg Tyra G,Mullikin James C,Merino Maria J,Bell Daphne W,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-884.pdf

Reference60 articles.

1. Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS: Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011, 8: 261-271. 10.1038/nrclinonc.2010.216.

2. Mahboubi E, Eyler N, Wynder EL: Epidemiology of cancer of the endometrium. Clin Obstet Gynecol. 1982, 25: 5-17. 10.1097/00003081-198203000-00004.

3. Dinkelspiel HE, Wright JD, Lewin SN, Herzog TJ: Contemporary clinical management of endometrial cancer. Obstet Gynecol Int. 2013, 2013: 583891-

4. Zighelboim I, Powell MA: Adjuvant treatment for early-stage endometrial cancer. Clin Obstet Gynecol. 2011, 54: 245-255. 10.1097/GRF.0b013e318218c5b8.

5. Trope C, Kristensen GB, Abeler VM: Clear-cell and papillary serous cancer: treatment options. Best Pract Res Clin Obstet Gynaecol. 2001, 15: 433-446. 10.1053/beog.2000.0187.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and Degradation;Advanced Science;2024-07-18

2. Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship;Bioorganic Chemistry;2023-01

3. Molecular subversion of Cdc42 signalling in cancer;Biochemical Society Transactions;2021-06-30

4. High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels;Cancer;2021-04-19

5. Endometrial cancer: a genetic point of view;Translational Cancer Research;2020-12